ALKS FY 2015 Earnings — Alkermes plc Revenue & Financial Results | Market Cap Arena

ALKSAlkermes plc

$5B

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$628M+1.5% YoY

Gross Profit

$489M77.9% margin

Operating Income

-$224M-35.7% margin

Net Income

-$227M-36.2% margin

EPS (Diluted)

$-1.52

Cash Flow

Operating Cash Flow

-$40M

Free Cash Flow

-$93M

Stock-Based Comp.

$97M

Balance Sheet

Total Assets

$1.9B

Total Liabilities

$541M

Stockholders' Equity

$1.3B

Cash & Equivalents

$181M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$628M	$619M	+1.5%
Gross Profit	$489M	$443M	+10.5%
Operating Income	-$224M	-$87M	-157.4%
Net Income	-$227M	-$30M	-655.7%